Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Spruce Biosciences (SPRB) FCF Margin (2023 - 2024)

Spruce Biosciences (SPRB) has disclosed FCF Margin for 2 consecutive years, with 2908.16% as the latest value for Q4 2024.

  • On a quarterly basis, FCF Margin fell 251990.0% to 2908.16% in Q4 2024 year-over-year; TTM through Sep 2025 was 6687.48%, a 603141.0% decrease, with the full-year FY2024 number at 1139.56%, down 80968.0% from a year prior.
  • FCF Margin was 2908.16% for Q4 2024 at Spruce Biosciences, down from 1537.17% in the prior quarter.
  • In the past five years, FCF Margin ranged from a high of 93.61% in Q2 2023 to a low of 2908.16% in Q4 2024.